First detection of the Anaplasma phagocytophilum groEL-A genotype in man

Elisabeth Haschke-Becher1, Rainer Bernauer, Anna-Maria Walleczek

  • 1Central Laboratory, University Hospital of Neurology, Paracelsus Medical University of Salzburg (PMU), Ignaz-Harrer-Strasse 79, A-5020 Salzburg, Austria.

The Journal of Infection
|December 29, 2009
PubMed
Abstract

Insights

Human Granulocytic Anaplasmosis (HGA) can be caused by two Anaplasma phagocytophilum genotypes. This study reports the first human detection of the groEL-A variant, alongside the previously known groEL-G variant.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Infectious Diseases

Background:

  • Human Granulocytic Anaplasmosis (HGA) is an emerging tick-borne illness caused by Anaplasma phagocytophilum.
  • The groEL gene within the groESL operon is a common PCR target for A. phagocytophilum detection.
  • A G/A polymorphism in the groEL gene distinguishes between groEL-G and groEL-A genotypes.

Observation:

  • Real-Time PCR was used to analyze DNA from two HGA patients.
  • The study aimed to genotype groEL-G and groEL-A variants of A. phagocytophilum.

Findings:

  • Two clinical HGA cases were confirmed via PCR.
  • The groEL-A variant of A. phagocytophilum was detected in one patient, marking its first identification in a human host.
  • The groEL-G variant was identified in the second patient.

Implications:

  • HGA infections are caused by at least two A. phagocytophilum groEL genotypes.
  • The prevalence and significance of the groEL-A genotype in human infections require further investigation.
  • Additional data from HGA patients are necessary for a comprehensive understanding of A. phagocytophilum genotype distribution.

Related Concept Videos